Many shareholders are very fearful of Big Pharma sabotaging

New Post Public Reply Private Reply Replies (2) Message Board
Cassandra X
560
Many shareholders are very fearful of Big Pharma sabotaging the efforts of Cytodyn to get Leronlimab approved for the long list of morbidities that LL can treat.

They think that the long arm of BP might sabotage the Brazil trials or the cancer trials or the NASH trials.

It is true that Cytodyn and LL are a threat to many of BPs crown jewels and the Drug Industry as a whole. But, as some BPs may wish to hurt Cytodyn, others may come to Cytodyn's aid to curry favor with Cytodyn in order to get a piece of Cytodyn's action.

In the drug industry it is true, to a greater or lesser extent, that each is at war with all. If one BP caught another BP trying to mess up Cytodyn, they would almost inevitably try to turn that knowledge to their advantage, not just let it continue.

A smart BP would try to protect Cytodyn from a rival and get a sweet deal with Cytodyn for an indication or two in a partnership. Plus get the cheater in trouble with the regulatory agencies. A big fat fine for the cheater would seem to be an incentive and a deterent to the players in the BP game.



Some people are observing that Cytodyn seems to be performing in a wiser fashion these days. I think they have found some friends. Hopefully some of those friends have some loose change that they can help Cytodyn out with as well. Samsung has certainly been friendly.


CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Deion Sanders Joins Depend: A Men's Health Push

Updated Category News Views 5

Coach Prime's New Role Just when you thought you'd heard it all in the marketing world, here comes Deion "Coach Prime" Sanders stepping up as the new face of Depend Real Fit® packaging. And why not? It's Men's Health Month—time for a wake-up call that might actually stick, if Sanders has anything to do with it. A Heavyweight Move for Proactive Health Depend® is...

Continue Reading
Inflation in Spain Experiences Slight Increase to 1.8% in October

Updated Category News Views 106

Spain's Inflation Rate Overview Spain has seen a slight increase in its European Union-harmonised 12-month inflation rate, which reached 1.8% in October, up from 1.7% in September. This information comes from preliminary data released by the National Statistics Institute (INE) on a recent Wednesday. Current Inflation Figures The latest figures align closely with the...

Continue Reading
Hyster-Yale Third Quarter Financial Performance Review

Updated Category News Views 133

Q3 2025 Consolidated Highlights Consolidated revenue reached $979 million, a 2% increase sequentially, yet a 4% decline on a year-over-year basis. Operating profit fell compared to the previous year due to elevated tariffs and reduced truck volumes. Operating cash flow improved to $37 million, reflecting enhanced inventory efficiency. Hyster-Yale, Inc. (NYSE: HY) reported...

Continue Reading
BigID Pioneers Data Labeling in Vector Databases for AI Security

Updated Category News Views 288

BigID Revolutionizes AI Data Security with New Capabilities BigID leads the charge in data security and privacy management, introducing a groundbreaking capability that enables data labeling in vector databases. This innovative step marks a significant advancement in ensuring secure AI access and sets an industry benchmark for how organizations manage sensitive data....

Continue Reading
First Horizon Corporation Plans Major Stock Redemption Announcement

Updated Category News Views 139

Stock Redemption Announcement by First Horizon Corporation First Horizon Corporation (NYSE: FHN) has made an important announcement regarding its financial strategy. The company will be redeeming all outstanding shares of its 6.625% Fixed-to-Floating Non-Cumulative Perpetual Preferred Stock, Series B, along with the associated depositary shares. This decision illustrates...

Continue Reading